Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?

References

• World Health Organization. Maintaining Essential Health Services: Operational Guidance for the COVID-19 Context: Interim Guidance. Geneva: World Health Organization; 2020.
   Google Scholar
• Sajjan US. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulm Med. 2013;19(2):125–132. doi:10.1097/MCP.0b013e32835cef10
   PubMed Web of Science ®Google Scholar
• Shukla SD, Mahmood MQ, Weston S, et al. The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL). Respir Res. 2017;18(1):6. doi:10.1186/s12931-016-0483-8
   PubMedGoogle Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100789. doi:10.1016/j.eclinm.2021.100789
   PubMedGoogle Scholar
• Lee SC, Son KJ, Han CH, Park SC, Jung JY. Impact of COPD on COVID-19 prognosis: a nationwide population-based study in South Korea. Sci Rep. 2021;11(1):3735. doi:10.1038/s41598-021-83226-9
   PubMed Web of Science ®Google Scholar
• Rabbani G, Shariful Islam SM, Rahman MA, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021;15(5):705–716. doi:10.1080/17476348.2021.1866547
   PubMed Web of Science ®Google Scholar
• Meza D, Khuder B, Bailey JI, Rosenberg SR, Kalhan R, Reyfman PA. Mortality from COVID-19 in Patients with COPD: a US Study in the N3C Data Enclave. Int J Chron Obstruct Pulmon Dis. 2021;16:2323–2326. doi:10.2147/COPD.S318000
   PubMed Web of Science ®Google Scholar
• Stridsman C, Vanfleteren LEGW, Konradsen JR, et al. Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD. Eur Respir J. 2021;58(5):2101920. doi:10.1183/13993003.01920-2021
   PubMed Web of Science ®Google Scholar
• De Miguel-Diez J, Lopez-de-Andres A, Jimenez-Garcia R, et al. Sex differences in COVID-19 hospitalization and hospital mortality among patients with COPD in Spain: a retrospective cohort study. Viruses. 2022;14(6):1238. doi:10.3390/v14061238
   PubMed Web of Science ®Google Scholar
• Shin E, Jin J, Park SY, et al. Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019. Asia Pac Allergy. 2022;12(2):e21. doi:10.5415/apallergy.2022.12.e21
   PubMed Web of Science ®Google Scholar
• Yazar EE, Yiğitbaş BA, Öztürk C, et al. Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study-a national, multicenter cross-sectional observational study. Turk J Med Sci. 2022;52(4):1130–1138. doi:10.55730/1300-0144.5416
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704–711. doi:10.1016/S0140-6736(09)61301-5
   PubMed Web of Science ®Google Scholar
• Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909–923. doi:10.1016/S2213-2600(21)00095-3
   PubMed Web of Science ®Google Scholar
• Izcovich A, Ragusa MA, Tortosa F, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One. 2020;15(11):e0241955. doi:10.1371/journal.pone.0241955
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
   PubMed Web of Science ®Google Scholar
• Al Sulaiman K, Aljuhani O, Al Aamer K, et al. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: a Multicenter, Cohort Study. J Intensive Care Med. 2022;37(2):248–257. doi:10.1177/08850666211053548
   PubMed Web of Science ®Google Scholar
• Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8(11):1106–1120. doi:10.1016/S2213-2600(20)30415-X
   PubMed Web of Science ®Google Scholar
• Pavord ID, Lettis S, Anzueto A, Barnes N. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med. 2016;4(9):731–741. doi:10.1016/S2213-2600(16)30148-5
   PubMed Web of Science ®Google Scholar
• Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. doi:10.1186/s40001-020-00432-3
   PubMed Web of Science ®Google Scholar
• Huang R, Xie L, He J, Dong H, Liu T. Association between the peripheral blood eosinophil counts and COVID-19: a meta-analysis. Medicine. 2021;100(23):e26047. doi:10.1097/MD.0000000000026047
   PubMed Web of Science ®Google Scholar
• Abu Hussein N, Ter Riet G, Schoenenberger L, et al. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts. Respiration. 2014;88(3):208–214. doi:10.1159/000363770
   PubMed Web of Science ®Google Scholar
• Keene SJ, Jordan RE, Franssen FM, et al. External validation of the updated ADO score in COPD patients from the Birmingham COPD cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:2395. doi:10.2147/COPD.S212381
   PubMed Web of Science ®Google Scholar